183 related articles for article (PubMed ID: 22151825)
1. Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: a historical prospective study.
Schmilovitz-Weiss H; Tobar A; Halpern M; Levy I; Shabtai E; Ben-Ari Z
Diagn Pathol; 2011 Dec; 6():121. PubMed ID: 22151825
[TBL] [Abstract][Full Text] [Related]
2. Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma.
Giannelli G; Marinosci F; Sgarra C; Lupo L; Dentico P; Antonaci S
Int J Cancer; 2005 Sep; 116(4):579-83. PubMed ID: 15825162
[TBL] [Abstract][Full Text] [Related]
3. Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC.
Trerotoli P; Fransvea E; Angelotti U; Antonaci G; Lupo L; Mazzocca A; Mangia A; Antonaci S; Giannelli G
Mol Cancer; 2009 May; 8():29. PubMed ID: 19473531
[TBL] [Abstract][Full Text] [Related]
4. Expression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosis.
Shi W; Hu J; Zhu S; Shen X; Zhang X; Yang C; Gao H; Zhang H
Int J Clin Exp Pathol; 2015; 8(10):13083-9. PubMed ID: 26722504
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC).
Pozzan C; Cardin R; Piciocchi M; Cazzagon N; Maddalo G; Vanin V; Giacomin A; Pontisso P; Cillo U; Farinati F
J Gastroenterol Hepatol; 2014 Aug; 29(8):1637-44. PubMed ID: 24635038
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of squamous cell carcinoma antigen 1 is associated with the onset and progression of human hepatocellular carcinoma.
Liu J; Gao Y; Yang B; Jia X; Zhai D; Li S; Zhang Q; Jing L; Wang Y; Du Z; Wang Y
Arch Med Res; 2015 Feb; 46(2):133-41. PubMed ID: 25819271
[TBL] [Abstract][Full Text] [Related]
7. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.
Guarino M; Di Costanzo GG; Gallotta A; Tortora R; Paneghetti L; Auriemma F; Tuccillo C; Fassina G; Caporaso N; Morisco F
Scand J Clin Lab Invest; 2017 Oct; 77(6):448-453. PubMed ID: 28609160
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients.
Hussein MM; Ibrahim AA; Abdella HM; Montasser IF; Hassan MI
Indian J Cancer; 2008; 45(4):167-72. PubMed ID: 19112206
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma antigen in human liver carcinogenesis.
Guido M; Roskams T; Pontisso P; Fassan M; Thung SN; Giacomelli L; Sergio A; Farinati F; Cillo U; Rugge M
J Clin Pathol; 2008 Apr; 61(4):445-7. PubMed ID: 17893121
[TBL] [Abstract][Full Text] [Related]
10. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis.
Liu CH; Gil-Gómez A; Ampuero J; Romero-Gómez M
Liver Int; 2018 Oct; 38(10):1820-1831. PubMed ID: 29704434
[TBL] [Abstract][Full Text] [Related]
12. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G
Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222
[TBL] [Abstract][Full Text] [Related]
13. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
[TBL] [Abstract][Full Text] [Related]
15. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma.
Pontisso P; Calabrese F; Benvegnù L; Lise M; Belluco C; Ruvoletto MG; Marino M; Valente M; Nitti D; Gatta A; Fassina G
Br J Cancer; 2004 Feb; 90(4):833-7. PubMed ID: 14970861
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis.
Yu J; Wang ZJ; Chen LH; Dong WZ
Scand J Clin Lab Invest; 2017 Feb; 77(1):8-14. PubMed ID: 27762143
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study.
Biasiolo A; Trotta E; Fasolato S; Ruvoletto M; Martini A; Gallotta A; Fassina G; Angeli P; Gatta A; Pontisso P
Dig Liver Dis; 2016 Feb; 48(2):197-202. PubMed ID: 26614642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
